The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib combined with carboplatin/paclitaxel and maintenance anlotinib as front-line treatment for newly diagnosed advanced ovarian cancer: A phase II, single-arm, multicenter study (ALTER-GO-010).
 
Yi Jiang
No Relationships to Disclose
 
Yingchun Gao
No Relationships to Disclose
 
Huaijun Zhou
No Relationships to Disclose
 
Yulang Cai
No Relationships to Disclose
 
Jinjin Yu
No Relationships to Disclose
 
Youguo Chen
No Relationships to Disclose
 
Jinling Xue
No Relationships to Disclose
 
Wenjun Cheng
No Relationships to Disclose